ZenO - Deep Cellular Oxygenation for Vitality & Longevity

What Makes ZenO a Novel Therapeutic Innovation?

ZenO’s underlying science establishes a distinct therapeutic category by addressing "Three Key Pillars" - which are the breakthrough in conventional oxygenation.

At sea - level normal breathing is limited by hemoglobin saturation. Once Hb is "full" (due to limited carriage capacity), you cannot carry more O₂ via RBCs (size >7um ), no matter how deeply you breathe. ZenO, however generates far more dissolved O₂ in plasma than normal breathing because high-concentrated ionized oxygen (350K PPM) forcing huge amounts of O₂ directly into the liquid part of blood—something the lungs alone cannot do.

The 3 main Pillars of ZenO's Properties:

Deep Tissue Penetration: Plasma oxygen diffusion into micro-capillaries enables delivery to tissues that red blood cells cannot reach.
Direct Mitochondrial Support: Oxygen directly feeds the electron transport chain, restoring ATP production.
Stem Cell Activation: CD34⁺⁺ mobilization and angiogenesis promote long-term tissue repair.

This multi‑pillar mechanism transforms oxygen from a passive gas into an active therapeutic effect — enabling both immediate cellular recovery and long‑term biological repair. Together, all these mechanisms yield a therapeutic profile with benefits similar to hyperbaric oxygen therapy (HBOT) — delivered in a non-invasive, daily-use format.

ZenO Pillar #1: Plasma Flood Oxygen Delivery (Deep Tissue O2 Penetration)

Traditional oxygen delivery relies on red blood cells (RBCs). But RBCs are 7.5 μm, too large to diffuse into damaged/inflammed mocro- capillaries. ZenO, high concentrations of oxygen (up to 350,000 ppm) dissolved in saturates blood plasma (<0.01 μm) to bypass circulatory bottlenecks and reaches damaged or inflamed micro‑capillaries RBCs cannot enter. ZenO also uses direct mucosal absorption, meaning oxygen enters the bloodstream without relying on lung function.This secondary route is what makes ZenO work even when circulation or lung efficiency is compromised.

Why these matters

Plasma (size<0.01 μm) carries dissolved Oxygen bypasses the RBC (size >7.5 μm) bottleneck.
Deep Tissue O2 Penetration - Oxygen reaches “oxygen‑starved” cells immediately.
ATP production rebounds quickly.
Inflammation begins to fall.

ZenO Pillar #2: Mito-HIF Advantage (ZenO switches "OFF" HIF‑1α and retore Mitochondria to stop inflammation)

When oxygen levels are low, your cells go into a state of stress. This happens because Hypoxia (low oxygen) disrupts mitochondria and activates stress pathways HIF‑1α, a protein which acts like an "inflammation alarm". When this HIF‑1α constaltly stays active will lead to long-term inflammation and the buildup of toxic waste products known as Reactive Oxygen Species (ROS).

ZenO changes this by flooding your cells with high levels of oxygen. This surge of oxygen activates a special enzyme called PHD that physically destroys the HIF-1α protein. By getting rid of this protein, ZenO effectively "Turns Off" the cell's inflammation alarm. Once the alarm is OFF or silenced, the cell’s power factories (mitochondria) can start working cleanly and efficiently again. This reset restore mitochondria, stops the cycle of tissue damage and swelling and significantly reduces the production of harmful inflammatory chemicals in the body.

Therapeutic effects

Higher ATP output (restored aerobic metabolism)
Reduced oxidative stress (neutralizing free radicals)
Moderated hypoxia signals (less cellular distress)
Protection against metabolic exhaustion (tissue integrity preserved)
Users feel clearer, stronger, and less fatigued — it’s mitochondrial rescue.

ZenO breaks the cycle (Hypoxia → Disease → Worse Hypoxia → Worst Disease) by restoring oxygen and activating repair simultaneously.

ZenO Pillar #3: Stem Cell Synergy

(ZenO activates Endogenous Stem Cells)

ZenO, high levels of plasma oxygen act as a biological signal that activates CD34++ stem cells from bone marrow. The CD34⁺⁺ mobilization results in angiogenesis which create long‑term repair.

Because Pillar #2 has already cleared the "fog" of inflammation and ROS, these stem cells (your own endogeneous cells) has the properties of "Homming" benefits lead to:

• Stem cells travel to damaged tissues.

• Initiate angiogenesis (forming new blood vessel) and tissue regenration.

• Release of Endopgeneous (your own) Stem Cells which are zero risk of rejection and 100% biological compatibility.

What happens next

Stem cells travel to damaged tissues.
They initiate angiogenesis (new blood vessel formation).
Tissue reneration - they rebuild tissue using your own biology — zero rejection risk.
Immediate: oxygen restores ATP, reduces inflammation.
Long‑term: stem cells repair and restore microcirculation.

Scientific Foundation: HBOT and Stem Cell Mobilization

A landmark 2006 study led by Dr. Stephen Thom at the University of Pennsylvania established that hyperbaric oxygen therapy (HBOT) administered at 2.0 ATA for two hours stimulates nitric oxide (NO) synthesis within the bone marrow. This rapid increase in NO (Nitric Oxide) activates enzymatic pathways that trigger the release of stem cell factor (SCF), signaling bone marrow niches to mobilize CD34++ hematopoietic and endothelial progenitor cells directly into peripheral circulation.

Validating ZenO Against HBOT Benchmarks

ZenO aims to replicate the physiological benefits of Hyperbaric Oxygen Therapy (HBOT) by elevating tissue oxygen levels. For individuals seeking independent, empirical verification of these claims, testing is available through flow cytometry at the ICT Stem Cells Lab Centre (advance reservation required; nominal fees may apply).

This verification protocol quantifies circulating CD34++ stem cell mobilization by analyzing and comparing blood samples drawn immediately prior to consumption and two hours following a 60 ml dose of ZenO.